These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30266666)

  • 1. Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye.
    Santer V; Chen Y; Kalia YN
    Eur J Pharm Biopharm; 2018 Nov; 132():157-167. PubMed ID: 30266666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted intracorneal delivery-Biodistribution of triamcinolone acetonide following topical iontophoresis of cationic amino acid ester prodrugs.
    Santer V; Del Río Sancho S; Lapteva M; Kalia YN
    Int J Pharm; 2017 Jun; 525(1):43-53. PubMed ID: 28414134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection.
    Nan K; Sun S; Li Y; Qu J; Li G; Luo L; Chen H; Cheng L
    Br J Ophthalmol; 2010 May; 94(5):654-8. PubMed ID: 20447969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-duration ocular iontophoresis of ionizable aciclovir prodrugs: A new approach to treat herpes simplex infections in the anterior and posterior segments of the eye.
    Chen Y; Kalia YN
    Int J Pharm; 2018 Jan; 536(1):292-300. PubMed ID: 29198810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ocular pigmentation on transscleral delivery of triamcinolone acetonide.
    Du W; Sun S; Xu Y; Li J; Zhao C; Lan B; Chen H; Cheng L
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):633-8. PubMed ID: 23597073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
    Chen Y; Zahui T; Alberti I; Kalia YN
    Eur J Pharm Biopharm; 2016 Feb; 99():94-102. PubMed ID: 26592154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).
    Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L
    Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
    Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
    Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
    Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.
    Molokhia SA; Jeong EK; Higuchi WI; Li SK
    Int J Pharm; 2007 Apr; 335(1-2):46-53. PubMed ID: 17236728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye.
    Roy G; Garg P; Venuganti VVK
    Int J Pharm; 2022 Jan; 612():121305. PubMed ID: 34800618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection.
    Cheng L; Banker AS; Martin M; Kozak I; Freeman WR
    Ophthalmology; 2009 Jul; 116(7):1356-9. PubMed ID: 19450879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcleral delivery of triamcinolone acetonide and ranibizumab to retinal tissues using macroesis.
    Singh RP; Mathews ME; Kaufman M; Riga A
    Br J Ophthalmol; 2010 Feb; 94(2):170-3. PubMed ID: 20139290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.